AstraZeneca PLC (AZN)
201.92
+0.16
(+0.08%)
USD |
NYSE |
Mar 04, 13:03
AstraZeneca Research and Development Expense (Annual) : 13.84B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| GSK Plc | 9.895B |
| Mereo BioPharma Group Plc | 20.94M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Biodexa Pharmaceuticals Plc | 6.679M |
| Bicycle Therapeutics Plc | 216.26M |